EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Impact of low‐volume blood withdrawal on hematological biomarkers for the athlete biological passport

B Krumm iD, J J Saugy, F Botrè, R Faiss iD

Drug Testing and Analysis · 2024

DOI: 10.1002/dta.3528 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Testing and Analysis, 2024. Verfasst von B Krumm und 3 weiteren Autor:innen. Beteiligte Einrichtung: REDs, Research & Expertise in anti-Doping sciences, Institute of Sport Sciences, University of Lausanne, Lausanne, Switzerland. Hauptthemen laut MEDLINE: Doping in Sports. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study investigated the impact of low‐volume blood withdrawal on the hematological biomarkers currently considered for anti‐doping purposes. After baseline measurement (D − 7), a 140 mL blood withdrawal was completed (D + 0) on 12 healthy volunteers, followed by weekly monitoring for 21 days (D + 7 – 21). Each visit consisted of a full blood count (Sysmex XN‐1000) and duplicate blood volume measurements by CO‐rebreathing. A significant decrease in total hemoglobin mass (Hbmass) (−2.3%, p = 0.007) and red blood cell volume (RBCV) (−2.8%, p = 0.028) was reported at D + 7. Despite no atypical passport finding (ATPF) when considering the athlete biological passport adaptive longitudinal model, hemoglobin concentration ([Hb]) increased significantly at D + 21 (+3.8%, p = 0.031). Besides, ferritin (FERR) was significantly downregulated at all points following blood withdrawal, with the largest decrease occurring at D + 7 (−26.6%, p < 0.001). Regardless of the presumable effect of blood reinfusion on ABP biomarkers, these results illustrate the challenge of monitoring hematological variables for the detection of low‐volume blood withdrawal. Finally, this study outlines the sensitivity of FERR to altered erythropoiesis to support the implementation of iron markers as complementary variables for the longitudinal monitoring of blood doping, despite the potential influence of confounding factors (e.g., iron supplementations).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Doping in SportsHumansIronAthletesBiomarkersFerritinsHemoglobinsSubstance Abuse Detection

Stichwörter der Autor:innen

athlete biological passportblood dopingblood transfusionblood withdrawalhematology

Substanzen

IronBiomarkersFerritinsHemoglobins

Autor:innen und Institutionen

  • REDs, Research & Expertise in anti-Doping sciences, Institute of Sport Sciences, University of Lausanne, Lausanne, Switzerland.

ORCID-Profile: B Krumm, R Faiss

Zitieren

APA

Krumm, B., Saugy, J. J., Botrè, F., & Faiss, R. (2024). Impact of low‐volume blood withdrawal on hematological biomarkers for the athlete biological passport. Drug Testing and Analysis. https://doi.org/10.1002/dta.3528

Vancouver

Krumm B, Saugy JJ, Botrè F, Faiss R. Impact of low‐volume blood withdrawal on hematological biomarkers for the athlete biological passport. Drug Testing and Analysis. 2024. doi:10.1002/dta.3528

BibTeX
@article{Krumm2024,
  author = {Krumm, B and Saugy, J J and Botrè, F and Faiss, R},
  title = {Impact of low‐volume blood withdrawal on hematological biomarkers for the athlete biological passport},
  journal = {Drug Testing and Analysis},
  year = {2024},
  doi = {10.1002/dta.3528}
}
Kostenlos starten →